It's good that they are not doing RS now, because if it they did it now it would be under the duress of weakness.
Lanza sold 1,338,490 shares on 12/14/012 at near 0.059 per share for about $79K, he still ownes 26,476,222 shares.
Gary always said they would get uplisting approval before doing the RS. No suprise here.
huge!!! This was the only reason many of us would not consider buying even on good news. Very tough but reasonable decision..still all good news
Sentiment: Strong Buy
The guy sold 5% of his total outstanding shares. I have no problem with that.
Gaeltown
Sentiment: Hold
Correct, Lanza selling not an issue at this time, his selling, preplanned or not, at the spike after the first scientific results was an issue.
Not being able to get listing on the NASDAQ at the present time which in my opinion is the real underlying problem, is also an issue.
Here a conspiracy theory for you. Rabin purposely kills the stock price to allow his butt buddies to buy in for cheap.
Rabin is a dumb #$%$. You don't announce a RS and then wait for the pps to go up to do it, while early in a PH1 trial.